Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit.
Saved in:
| Title: | Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. |
|---|---|
| Authors: | Kawatkar A; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Clark RA; Discovery Sciences, R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Hopcroft L; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Roaquin DA; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Tomlinson R; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Zuhl AM; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Lamont GM; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Kettle JG; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Critchlow SE; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Castaldi MP; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States., Goldberg FW; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K., Zhang AX; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States. |
| Source: | ACS chemical biology [ACS Chem Biol] 2023 Feb 17; Vol. 18 (2), pp. 296-303. Date of Electronic Publication: 2023 Jan 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36602435 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kawatkar+A%22">Kawatkar A</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States.<br /><searchLink fieldCode="AU" term="%22Clark+RA%22">Clark RA</searchLink>; Discovery Sciences, R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Hopcroft+L%22">Hopcroft L</searchLink>; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Roaquin+DA%22">Roaquin DA</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States.<br /><searchLink fieldCode="AU" term="%22Tomlinson+R%22">Tomlinson R</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States.<br /><searchLink fieldCode="AU" term="%22Zuhl+AM%22">Zuhl AM</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States.<br /><searchLink fieldCode="AU" term="%22Lamont+GM%22">Lamont GM</searchLink>; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Kettle+JG%22">Kettle JG</searchLink>; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Critchlow+SE%22">Critchlow SE</searchLink>; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Castaldi+MP%22">Castaldi MP</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States.<br /><searchLink fieldCode="AU" term="%22Goldberg+FW%22">Goldberg FW</searchLink>; Oncology R&D, AstraZeneca, CambridgeCB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Zhang+AX%22">Zhang AX</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts02451, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101282906%22">ACS chemical biology</searchLink> [ACS Chem Biol] 2023 Feb 17; Vol. 18 (2), pp. 296-303. <i>Date of Electronic Publication: </i>2023 Jan 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101282906 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1554-8937 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215548929%22">15548929 </searchLink><i>NLM ISO Abbreviation: </i>ACS Chem Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36602435 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acschembio.2c00666 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 296 Titles: – TitleFull: Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kawatkar A – PersonEntity: Name: NameFull: Clark RA – PersonEntity: Name: NameFull: Hopcroft L – PersonEntity: Name: NameFull: Roaquin DA – PersonEntity: Name: NameFull: Tomlinson R – PersonEntity: Name: NameFull: Zuhl AM – PersonEntity: Name: NameFull: Lamont GM – PersonEntity: Name: NameFull: Kettle JG – PersonEntity: Name: NameFull: Critchlow SE – PersonEntity: Name: NameFull: Castaldi MP – PersonEntity: Name: NameFull: Goldberg FW – PersonEntity: Name: NameFull: Zhang AX IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 02 Text: 2023 Feb 17 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1554-8937 Numbering: – Type: volume Value: 18 – Type: issue Value: 2 Titles: – TitleFull: ACS chemical biology Type: main |
| ResultId | 1 |